Hepatology (Baltimore, Md.)
Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.
NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis.
Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality?
Acute hepatic porphyrias: Recommendations for evaluation and long-term management.
Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cells.
Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile?
